What is Armac?
For over four decades, Armac has functioned as a critical intermediary in the healthcare supply chain, specializing in the provision of orthopedic bracing, custom orthotics, and prosthetics. The company distinguishes itself through a comprehensive inventory management service that eliminates the administrative burden for medical professionals, allowing them to prioritize patient outcomes. By managing the stocking and billing processes internally, Armac removes third-party friction, creating a streamlined delivery system that serves hospitals, physicians, and insurance entities with high reliability. Their commitment to the New Jersey medical community has established them as a trusted partner in the rehabilitation sector, characterized by a focus on direct-to-client service and logistical precision.
How much funding has Armac raised?
Armac has raised a total of $455K across 2 funding rounds:
Debt
$150K
Debt
$305K
Debt (2020): $150K with participation from PPP
Debt (2021): $305K led by PPP
Key Investors in Armac
PPP
Public-Private Partnership
What's next for Armac?
With the recent injection of capital, Armac is expected to focus on optimizing its supply chain logistics and expanding its footprint within the regional healthcare ecosystem. The strategic deployment of these funds will likely target the enhancement of their proprietary inventory management systems, ensuring that the company can meet the increasing demand for durable medical equipment with greater agility. As the healthcare industry continues to emphasize cost-efficiency and patient-centric care, Armac's ability to integrate seamlessly into clinical workflows provides a distinct competitive advantage. Future growth initiatives will likely involve scaling their direct-service model to accommodate a larger volume of orthopedic and prosthetic requirements, further cementing their role as an essential service provider in the medical rehabilitation space.
See full Armac company page
